MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Launched by HOFFMANN-LA ROCHE · Oct 24, 2002
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women 55-80 years of age;
- • post-menopausal for \>= 5 years;
- • ambulatory.
- Exclusion Criteria:
- • malignant disease diagnosed within the previous 10 years (except basal cell cancer that has been successfully removed);
- • breast cancer within the previous 20 years;
- • allergy to bisphosphonates;
- • previous treatment with an intravenous bisphosphonate at any time;
- • previous treatment with an oral bisphosphonate within the last 6 months, \>1 month of treatment within the last year, or \>3 months of treatment within the last 2 years.
About Hoffmann La Roche
Hoffmann-La Roche, commonly known as Roche, is a global leader in biotechnology and pharmaceuticals, committed to advancing healthcare through innovative research and development. With a strong focus on oncology, immunology, infectious diseases, and central nervous system disorders, Roche leverages cutting-edge science to deliver transformative therapies and diagnostics. The company is dedicated to improving patient outcomes by conducting rigorous clinical trials and collaborating with healthcare professionals and organizations worldwide. Roche's unwavering commitment to precision medicine and personalized healthcare positions it at the forefront of the industry, driving progress in the quest for effective treatments and improved patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Saint Louis, Missouri, United States
San Antonio, Texas, United States
Richmond, Virginia, United States
Calgary, Alberta, Canada
Zürich, , Switzerland
Omaha, Nebraska, United States
Warszawa, , Poland
Barcelona, , Spain
Madrid, , Spain
Madrid, , Spain
Southampton, , United Kingdom
Albuquerque, New Mexico, United States
San Antonio, Texas, United States
Seattle, Washington, United States
Albuquerque, New Mexico, United States
Seattle, Washington, United States
Richmond, Virginia, United States
Omaha, Nebraska, United States
Vancouver, British Columbia, Canada
Gainesville, Florida, United States
Berlin, , Germany
London, Greater London, United Kingdom
Berlin, , Germany
Billings, Montana, United States
Cardiff, South Glamorgan, United Kingdom
Madison, Wisconsin, United States
Portland, Oregon, United States
Toronto, Ontario, Canada
Quebec City, Quebec, Canada
Southampton, , United Kingdom
Saint Louis, Missouri, United States
Portland, Oregon, United States
Madison, Wisconsin, United States
Adelaide, , Australia
Perth, , Australia
Toronto, Ontario, Canada
Quebec City, Quebec, Canada
Krakow, , Poland
London, , United Kingdom
Irvine, California, United States
Loma Linda, California, United States
Oakland, California, United States
Rancho Mirage, California, United States
Lakewood, Colorado, United States
Gainesville, Florida, United States
Bethesda, Maryland, United States
Wheaton, Maryland, United States
Billings, Montana, United States
Livingston, New Jersey, United States
Wyomissing, Pennsylvania, United States
Parkville, , Australia
Liege, , Belgium
Merksem, , Belgium
Campinas, , Brazil
Curitiba, , Brazil
Porto Alegre, , Brazil
Sao Paulo, , Brazil
Calgary, Alberta, Canada
Plzen, , Czechia
Praha, , Czechia
Aalborg, , Denmark
Ballerup, , Denmark
Vejle, , Denmark
Caen, , France
Lyon, , France
Hannover, , Germany
Balatonfuered, , Hungary
Budapest, , Hungary
Kiskunhalas, , Hungary
Zalaegerszeg, , Hungary
Siena, , Italy
Valeggio Sul Mincio, , Italy
Leon, , Mexico
Obregon, , Mexico
Haugesund, , Norway
Oslo, , Norway
Stavanger, , Norway
Warszawa, , Poland
Bucharest, , Romania
Cape Town, , South Africa
Johannesburg, , South Africa
Barcelona, , Spain
Cardiff, , United Kingdom
Liverpool, , United Kingdom
Patients applied
Trial Officials
Clinical Trials
Study Director
Hoffmann-La Roche
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials